Package 50844-254-12

{"route": ["ORAL"], "spl_id": "17cb371b-3373-42aa-9706-f9e843474537", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "upc": ["0052548689964"], "unii": ["R16CO5Y76E"], "rxcui": ["212033"], "spl_set_id": ["e077fe14-62bb-462b-bfa3-8a83c06c22f1"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["L.N.K. International, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (50844-254-12)  / 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC", "package_ndc": "50844-254-12", "marketing_end_date": "20261031", "marketing_start_date": "20190715"}], "brand_name": "Coated Aspirin", "product_id": "50844-254_17cb371b-3373-42aa-9706-f9e843474537", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "50844-254", "generic_name": "Aspirin", "labeler_name": "L.N.K. International, Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Coated Aspirin", "active_ingredients": [{"name": "ASPIRIN", "strength": "325 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_end_date": "20261031", "marketing_start_date": "20190715"}